Safety and Efficacy Study of REOLYSIN® in the Treatment of Recurrent Malignant Gliomas

Clinical trial NCT00528684 · COMPLETED

Trial details

NCT number: NCT00528684
Sponsor: Oncolytics Biotech
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Malignant Glioma

Start date: 2006-07-01
Primary completion: 2010-04-01
Enrollment: 18

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.